This Combined Synopsis/Solicitation opportunity was posted on August 26, 2010. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

65--IMMUNOCAP 250 ANALYZER AND REAGENTS

Awarded

W91YU010T0214Federal

Submission Closed09/07/2010, 05:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

Federal

Blood Type IVD Reagents and Sera SupplyThis subcontract involves the supply of Blood Type IVD Reagents and Sera to prime contractors supporting Department of Veterans Affairs VISN 22 medical supply contracts. The scope of work includes the manufacture or distribution of ABO reverse typing cells, antibody screening cells, and antibody identification cells, as well as the provision of Lewis Blood Group Substance and full antigen profiles. All delivered reagents must be FDA compliant and accompanied by Certificates of Analysis or Conformance. The contract is managed by the Network Contract Office 22 under NAICS code 325413, with a response deadline set for November 16, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6550--Blood Type IVD Reagents

Solicitation # 36C26227Q0043

The Department of Veterans Affairs, through the Network Contract Office 22, is seeking quotations for solicitation 36C26227Q0043 to establish a Blanket Purchase Agreement for blood type IVD reagents, supplies, and consumables for manual testing at VISN 22 facilities. The contract is structured with a 12-month base ordering period and four subsequent 12-month option periods, for a total potential duration of five years. This is a commercial products and services acquisition under FAR Part 12, with an emphasis on FDA regulatory compliance, potency requirements, and strict cold-chain and temperature-monitoring controls during shipment. All items must be quoted as F.O.B. destination and delivered Monday through Friday between 8am and 4pm. Award will be based on the best value to the government, evaluated through a comparative assessment of technical understanding, price, and quality, regulatory compliance, and product traceability. Technical evaluation considers the offeror's ability to provide a full antigen profile and their procedures for handling nonconforming or defective products. Pricing will be evaluated based on the total cost for the base period and all option periods, including a six-month price addition for the final performance period per FAR 52.217-8. Quotations must be submitted via email to the contract specialist by November 16, 2026, and must include a completed five-year pricing spreadsheet, a past performance questionnaire, and required certifications regarding telecommunications and trade agreements.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Reagents and consumables for Roche immunostainers

Solicitation # 75N98027Q00026

Solicitation 75N98027Q00026 is a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract issued by the National Institutes of Health Office of Logistics and Operations. The objective is to procure proprietary reagents, kits, and consumables compatible with the National Cancer Institute's Roche Ventana Benchmark ULTRA and Benchmark Plus immunostainers. The contract includes a base year starting December 1, 2026, with four subsequent option years, carrying a minimum value of 20,000 dollars and a maximum value of 1.5 million dollars. The scope of work extends beyond supplies to include no-cost software upgrades, VConnect software coverage, and professional consultation from scientists and engineers. The contractor must adhere to strict quality and delivery standards, including overnight shipping using industry-best practices such as dry or wet ice, and ensuring all reagents have expiration dates exceeding 12 months from the shipping date. Deliveries are f.o.b. destination to Bethesda, Maryland, and must typically be completed within five days of a task order. Award will be based on a best value tradeoff evaluation considering technical proposal, equipment capability, delivery, and price. Offerors must provide a Unique Entity Identifier, Taxpayer Identification Number, and business size certification, with responses due by November 16, 2026.

National Institutes Of Health Olao

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-1071

Solicitation SPE2DS-27-T-1071, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of the order, with a final delivery date of October 30, 2026, to the USS IDAHO (SSN 799). The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires labels to include the contract or lot number and the date of manufacture, expiration, or retest. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area Workflow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CULTURE MEDIUM, THAYER-

Solicitation # SPE2DS-27-T-1066

Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of ALBAcyte Blood Bank ReagentsThis subcontract involves the manufacture and supply of specialized ALBAcyte blood bank reagents for prime contractors supporting the Department of Veterans Affairs North Texas Health Care System. The scope of work includes the delivery of A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated RBCs. To ensure product efficacy, the contractor must utilize shipping containers that maintain reagent integrity and adhere to a defined Quality Plan and FDA approval standards. Deliveries are to be made FOB Destination to the Transfusion Medicine Unit located in Dallas, Texas. The contract is categorized under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 17.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6550--Blood Bank Reagents

Solicitation # 36C25727Q0065

The Department of Veterans Affairs VA North Texas Health Care System is issuing a Sources Sought Notice to identify qualified vendors capable of providing blood bank reagents for the Transfusion Medicine Unit in Dallas, Texas. These reagents, including ALBAcyte A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated Red Blood Cells, are essential for manual blood typing and serum antibody detection used in cross-matching blood for transfusions. The anticipated acquisition strategy includes a base year starting May 1, 2027, with four subsequent one-year option periods extending through April 30, 2032. To be considered, vendors must be FDA approved, provide documentation of such approval, and maintain a defined quality plan with adequate supply availability. All shipments must be FOB Destination, and the contractor is responsible for providing appropriate shipping containers. Interested vendors must submit an electronic capability statement in PDF or Word format, including the place of manufacture for all listed reagents, to the designated contract specialist by November 5, 2026, at 9:00 AM CST. This notice is for market research purposes only to determine the appropriate acquisition strategy, such as a small business set-aside, and does not constitute a formal solicitation.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6505--DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)

Solicitation # 36C77027Q0015

The Department of Veterans Affairs, National CMOP Office, is conducting market research through a Sources Sought announcement to identify qualified sources for the procurement of Drawtex Dressing, 4in X 4in, packaged as 10ct per box. This action is for market research purposes only and is not a formal solicitation for quotes; therefore, no contract will be awarded based on this specific announcement. The place of performance is located in Ladson, South Carolina, and the primary point of contact is Contract Specialist Claudine Challinor. Interested respondents must submit their information via email by November 3, 2026. Required details include the company's SAM Unique ID Number, business size (Small, Large, SDVOSB, or VOSB), and point of contact information. Specifically, the government is seeking to determine if the respondent is the manufacturer, the manufacturer's product number, and the place of manufacturing. If the respondent is not the manufacturer, they must provide a letter of authorization from the original equipment manufacturer or provide detailed product literature and specifications for alternative products that demonstrate similarities to the Drawtex hydro conductive wound dressing.

National Cmop Office (36C770)

POSTED

DEADLINE

6550--Optilite analyzer reagents

Solicitation # 36C26227Q0052

The Department of Veterans Affairs, Southern Arizona Healthcare System, is soliciting a Firm-Fixed Price Blanket Purchase Agreement under solicitation 36C26227Q0052 for the procurement of FDA-approved reference testing reagents and consumables validated for use on the Optilite analyzer. The scope includes specific items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagents, as well as TENCELL cuvettes and sample cups. To ensure system performance and safety, all materials must be manufactured by Binding Site Laboratories, and substitutions are prohibited. The contract is issued as a full and open competition under NAICS code 325413, with a total estimated period of performance of sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. The award will be granted to the responsible offeror whose proposal is most advantageous to the government, based on a technical acceptability review of the Statement of Work and the lowest price. Deliveries are required to be made to various VA Medical Centers across Arizona, California, and New Mexico, with standard orders delivered within four working days of placement. All shipments must be destination-based, with the vendor assuming all shipping costs and adhering to strict packaging standards to prevent damage. Invoicing is handled electronically through the Department of Veterans Affairs Financial Services Center in accordance with the Prompt Payment Act. Quotes must be submitted via email to Contract Specialist Carlos Magana by November 4, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Supply of i-STAT PT Plus Control Reagent Level 1This subcontract involves the procurement and delivery of i-STAT PT Plus Control Reagent Level 1 for coagulation testing to support prime contractors fulfilling Department of Defense supply contracts. The scope of work requires the delivery of two boxes, each containing ten 1.0 mL units, shipped FOB Destination to a performance location in APO 96260-5479. To ensure quality and safety, all supplied reagents must adhere to Regulation 864.7750 Class II requirements and maintain full compliance with Registration, Listing, Labeling, and Good Manufacturing Practices. This requirement is managed under NAICS code 325413 for the Medical Supply Chain MD Surg FSF agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, BLOOD CHEM

Solicitation # SPE2DS-27-T-0906

Solicitation SPE2DS-27-T-0906 is a request for quotations from DLA Troop Support for two sets of DXH 500 Series Blood Chemistry Control (NSN 6550-01-688-9090). This assayed whole blood control is used to monitor multi-parameter hematology cell counters and includes abnormal low, normal, and abnormal high components. The items must be stored refrigerated and upright between 2 to 8 degrees Celsius and protected from freezing and overheating. Delivery is required within 20 days after receipt of order, with a required delivery date of October 27, 2026, under FOB Destination terms. The contract imposes strict shelf-life requirements, specifying a non-extendable shelf life of 3 months, with no more than 13 days elapsed from the date of manufacture to the date of delivery. Packaging must be commercial and compliant with RP001 and MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1. Invoicing is to be processed electronically via the Wide Area Workflow system. This is not a small business set-aside, and the procurement falls under NAICS code 325413. Compliance with the Buy American and Balance of Payments Program and DFARS safeguarding of covered defense information is required.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-27-T-0950

Solicitation SPE2DS-27-T-0950 is a Request for Quotations issued by the Department of Defense, DLA Troop Support Medical Supply Chain, for the procurement of two boxes of i-STAT PT Plus Control Reagent Level 1 (NSN 6550-01-728-5703). This reagent is used for coagulation testing and is compatible with the i-STAT PT Plus cartridge and the i-STAT 1 Government Field Kit analyzer. Each box contains ten 1.0 mL units. The required delivery date is October 23, 2026, with a delivery window of 83 days after award. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract mandates strict quality and storage requirements, including refrigeration between 2 to 8 degrees Celsius and a non-extendable shelf life of 12 months. Items must be delivered within one month of the manufacture date. Packaging must be commercial and adhere to MIL-STD-2073-1E and RP001, with marking compliant with Medical Marking Standard No. 1. Labels must include the contract/lot number and manufacture or expiration dates. The procurement is not a small business set-aside, though a HUBZone price evaluation preference may be applied. Compliance with the Buy American Act and DFARS domestic material restrictions is required, and electronic invoicing must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

5 days ago

DEADLINE

in 3 days

AI Contract Overview

The Western Regional Contracting Office for William Beaumont Army Medical Center is soliciting proposals for an Immunocap 250 Analyzer and associated reagents for the period of October 1, 2010, through September 30, 2011. The requirement includes one fully automated analyzer equipped with a computer, monitor, printer, data manager software, and UPS, capable of specific IgE allergy blood testing. The selected contractor is responsible for the unpacking, installation, verification, and training at the government site, as well as providing necessary equipment repair or replacement. In addition to the analyzer, the contract includes various reagents, calibrators, controls, and solutions to be ordered on an as-needed basis. Proposals will be evaluated based on technical capability and price, with the award granted to the lowest priced technically acceptable offeror. Interested parties must be registered in the Central Vendor Register and submit their offers by September 7, 2010.

General Info

Agency

N/A

Contract Value

$327,356.94

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Western Regional Contracting Office, WBAMC 5005 N PIEDRAS, BLDG 7115 EL PASO TX 79920 US, MI, USA

Set-Aside

NONE

Awardee

PHADIA US INC

Award Issued Date

09/17/2010, 12:00:00 AM UTC

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded

PostedAug 26

Combined Synopsis

AwardedSep 17

Contract was awarded

Submission Closed

09/07/2010, 05:00:00 AM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyN/A

ContactsNo contacts available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

ContactsNo contact information available

Full Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Western Regional Contracting Office (WRCO), William Beaumont Army Medical Center (WBAMC) has a requirement for a Immunocap Analyzer and Reagents. Shall be brand name or equal in accordance with the salient characteristics as stated in CLIN 0001of solicitation W91YU0-10-T-0214. This announcement is prepared in accordance with FAR Part 12 Commercial Items with additional information included in this notice. The associated North American Industrial Classification System (NAICS) code for this procurement is 325413. Standard Industrial Classification (SIC) 6550. To be eligible to receive an agreement with the federal government, interested parties must be registered in the Central Vendor Register (CCR) online at www.ccr.gov. All responsible Contractors shall provide an offer for the following Line items: 0001: IMMUNOCAP 250 ANALIZER (OR EQUAL), 1 EACH, Salient Characteristics: Include computer, monitor and printer, Immunocap data manager software, computer stand, and UPS. Must be fully automated with no shared carousels limiting capacity. Specific IgE allergy blood testing designed as a sandwich immunoassay with a turnaround time of one hour thirty seven minutes per test. With a solid phase cellulose derivative enclosed in a reaction vessel with a 40UL patient sample (serum or plasma). The IgE calibrators are traceable to the 2nd international referenced preparation 75/502 of human serum immunoglobulin E from world health organization. Immunocap 250 instrument measures total IgE concentration in kU/L and the instrument automatically calculates the quantitative concentration. Contractor shall unpack, install verify instrumentation operation and train at the Government site. Vendor shall also provide replacement or repair of equipment if necessary. PROPOSED PRODUCTS MUST BE BRAND NAME OR EQUAL, FOR THE PERIOD 01 OCTOBER 2010 THROUGH 30 SEPTEMBER 2011. THE FOLLOWING LINE ITEMS WILL BE ORDERED ON AS NEEDED BASIS. 0002: Specific IgE, 41 AF Immunocap, 140 0003: 41 SIR Specific IgE, Anti-Iege Immunocap carrier, 120 EACH 0004: 41 AS Immunocap Specific IgE Calibrator Strip, 20 EACH 0005: 41 BX Immunocap Specific IgE Curve Control Strip, 25 EACH 0006: 41 BX Immunocap Specific, 25 EACH 0007: 41 BX Immunocap Specific IgE Negative Control, 35 EACH 0008: 53GX Allergen Immunocap, 3,200 EACH 0009: 53FX Allergen Immunocap, 300 EACH 0010: 54DY Allergen Immunocap, 600 EACH 0011: 54DX Allergen Immunocap, 20 EACH 0012: 53DY Allergen Immunocap, 30 EACH 0013: 53DX Allergen Immunocap, 10 EACH 0014: 53EY Allergen Immunocap, 10 EACH 0015: 53EX Allergen Immunocap, 2 EACH 0016: 53HX Allergen Immunocap, 2 EACH 0017: 56XX Allergen Immunocap, 25 EACH 0018: 57XX Allergen Immunocap, 4 EACH 0019: 41SF Allergen Immunocap, 10 EACH 0020: 41SI Allergen Immunocap, 40 EACH 0021: 41SS Allergen Immunocap, 15 EACH 0022: 41BX Immunocap Total Curve Control Strip, 15 EACH 0023: 41BX Immunocap Total IgE Control (LMH), 30 EACH 0024: 41 AD Immunocap Development Solution, 80 EACH 0025: 41AD Immunocap Stop Solution, 80 EACH 0026: 53KX Washing Solution, 260 EACH 0027: 53BS Immunocap IgE/ECT/TRYTASE Sample Diluent, 3 EACH 0028: 53BS Immunocap Specific IgA/IgG Sample Diluent, 2 EACH 0029: 41BX Monthly Quality Assessment Program, Quality Club Specific IgE(KUA/L)3 Allergens, 5 EACH 0030: 41BX Quality Club Total IgE 2, 1 EACH 0031: Shipping and Handling , 3500 EACH 0032: Maintenance Solution Kit, 10 EACH The full text of a FAR provision or clause may be accessed electronically at www.farsite.hill.af.mil The following provisions will be included in the established agreements: 52.212-1 Instructions to Offerors-Commercial Items; Addendum to 52.212-1 Instructions to Vendors; 52.212-2 Evaluation-Commercial Items; The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government price and other factors considered. The following factors shall be used to evaluate offers: Technical capability, and price. To be technically acceptable the quote must meet the minimum characteristics shown in Line Item 0001, if providing an equal product, comply with FAR Part 52.211-6, Brand Name or Equal. The award decision will be based on the lowest priced technically acceptable, the offeror shall submit prices on all CLINs. 52.212-3 Offerors Representations and Certifications-Commercial Items. Offerors must complete FAR 52.212-3 Offerors Representations and Certifications Commercial items or do so on-line at http://orca.bpn.gov. The following clauses apply to this acquisition: 52.212-4 Contract Terms and Conditions Commercial Items; Addendum to 52.212-4 Contract Terms and Conditions Commercial Items; 52.203-6 Alt 1 Restrictions On Subcontractor Sales to the Government; 52.203-12 Limitation On Payments to Influence Certain Federal Transactions; 52.204-4 Printed or Copied Double-Sided on Recycled Paper; 52.204-10 Reporting Executive compensation and First Tier Subcontract Awards; 52.209-6 Protecting the Governments Interest when Subcontracting with contractors Debarred, Suspended, or Proposed for Debarment; 52.219-4 Notice of Price Evaluation Preference for HubZone Small Business Concerns; 52.222-19 Child Labor Cooperation with Authorities and Remedies; 52.222-21 Prohibition of Safeguard; 52-222-26 Equal Opportunity; 52.222-50 Combating Trafficking in Persons; 52.222-99 (Dev) Notification of Employee Rights under the National Labor Relations Act; 52.225-13 Restriction on Certain Foreign Purchases; 52.232-18 Availability of Funds; 52.232-33, Payment by Electronic Funds Transfer-Central Contractor Registration; 52.233-3 Protest After Award; 52.233-4 Applicable Law for Breach of Contract Claim; 52.242-13 Bankruptcy; 52.252-2 Clauses Incorporated by Reference; 52.252-6, Authorized Deviations in Clauses; 52.212-5 Contract Terms and conditions Required to Implement Statutes or Executive Orders Commercial Items (Deviation); 52.204-5 Women-Owned Business (Other Than Small Business); 52.211-6 Brand Name or Equal; 52.252-1 Solicitation Provisions Incorporated by Reference. The following DFARS clauses apply: 252.203-7000 Requirements Relating to Compensation Of Former DoD Officials; 252.203-7002 Requirement to Inform Employees of Whistleblower Rights; 252.204-7003 Control Of Government Personnel Work Product; 252.225-7001 Buy American Act and Balance of Payments Program; 252.232-7003 Electronic Submission of Payment Requests and Receiving Reports; 252.232-7010 Levies on Contract Payments; 252.212-7001 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Applicable to Defense Acquisitions of Commercial Items (Deviation); 252.209-7001 Disclosure of Ownership or Control by the Government of a Terrorist Country; 252.2127000 Offeror Representations and Certifications-Commercial Items; 252.225-7000 Buy American Act Balance Of Payments Program Certificate. WAWF Instructions (local clause available via e-mail request). Potential contractors must be registered in the Central Contractor Registry (CCR) to be eligible for award. The CCR internet web site is http://www.ccr.gov. Offers are due by 07 September 2010, 12:00PM Mountain Standard Time. Submit offers via fax to +1 (555) 000-0000 or email to contact@example.gov Deliver to: William Beaumont Army Medical Center, Medical Supply Officer BLDG 11156, Biggs Army Airfield FT Bliss, TX 79918-8006